Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses and other payables

v3.7.0.1
Accrued Expenses and other payables
6 Months Ended
Jun. 30, 2017
Accrued Liabilities, Current [Abstract]  
Accrued Expenses and other payables

6. Accrued Expenses and other payables


Accrued expenses and other payables consist of the following:


 

 

June 30,
2017

 

December 31,
2016

 

 

 

 

 

 

 

 

 

Accrued clinical trial and other expenses

 

$

519,820

 

$

580,218

 

Compensation and related benefits

 

 

35,295

 

 

642,532

 

Deferred rent

 

 

35,324

 

 

42,423

 

Patent fees

 

 

30,000

 

 

40,000

 

Other expenses related to Pelican acquisition

 

 

82,301

 

 

 

 

 

$

702,740

 

$

1,305,173

 


The decrease of compensation and related benefits was related to 2016 employee bonuses which were accrued at December 31, 2016 but subsequently paid in January 2017.